Validea Detailed Fundamental Analysis

Validea's guru fundamental report indicates that Emerson Electric (EMR) receives an 81% rating based on their Multi-Factor Investor model, which is based on the investment strategy of Pim van Vliet. The model favors low volatility stocks with strong momentum and high net payout yields. While EMR passes the market cap and standard deviation tests, it is neutral on momentum and net payout yield, ultimately failing the final rank within the strategy's criteria.

Analysis

Emerson Electric Co. (EMR), a large-cap growth stock in the Scientific & Technical Instruments industry, has been evaluated by Validea's Multi-Factor Investor model, based on Pim van Vliet's strategy targeting low-volatility stocks with strong momentum and high net payout yields. EMR received an 81% rating from this model, indicating "some interest" rather than strong conviction. While the company successfully passed criteria for market capitalization and standard deviation, signifying favorable low-volatility characteristics, it registered a "NEUTRAL" assessment on both "Twelve Minus One Momentum" and "Net Payout Yield". Consequently, despite these positive initial screens, EMR ultimately received a "FAIL" on the "FINAL RANK" within this specific strategy's framework. This outcome, reflected in a mildly negative sentiment score of -0.3 for EMR, suggests that while the stock exhibits desirable low-risk attributes, its current momentum and shareholder yield profile do not sufficiently meet the comprehensive requirements of van Vliet's conservative factor investing approach.

Key Decisions for Investors

• Investors should recognize EMR's favorable low-volatility profile, as evidenced by its passing grades on market capitalization and standard deviation tests, but must also acknowledge its neutral standing on momentum and net payout yield according to the Pim van Vliet model.
• The 'FAIL' in the final rank within this specific multi-factor strategy suggests EMR may not be an optimal holding for portfolios strictly prioritizing a combination of low risk with strong momentum and high net payout yields.
• Given the mixed assessment, further due diligence on EMR's fundamental growth drivers and shareholder return policies is advisable, particularly for investors who heavily weigh quantitative factor models in their decision-making process.